The mortality and chronic bronchitis health endpoints are the most influential in our estimation of monetized benefits, because they account for over 95 percent of the total estimated monetized benefits of the Clear Skies Act.
Bronchitis health endpoints influence how benefits are monetized by insurance companies and the EPA.